CEMIP and colorectal cancer: CEMIP is more than just a highly upregulated biomarker in CRC, as the enhanced expression of CEMIP has also been associated with poor prognosis in colorectal cancer patients [8,11,12,16] and is an independent prognostic factor in this context [11,16].